Cephalosporin and Azithromycin Susceptibility in Neisseria Gonorrhoeae Isolates by Site of Infection, British Columbia, 2006-2011
Travis Salway Hottes, MSc1, Richard T. Lester, MD, FRCPC1, Linda MN Hoang, MSc, MD, FRCPC2, Rachel McKay, MSc3, Miguel Imperial, MD, FRCPC2, Mark Gilbert, MD, MHSc, FRCPC1, David Patrick, MD, FRCPC, MHSc3, Tom Wong, MD, MPH, FRCPC4, Irene Martin, BSc5 and Gina Ogilvie, MD, MSc, CCFP, FCFP, DrPH(C)1, 1Clinical Prevention Services, British Columbia Centre for Disease Control, Vancouver, BC, Canada, 2Laboratory Services, British Columbia Centre for Disease Control, Vancouver, BC, Canada, 3Communicable Disease Prevention and Control Services, British Columbia Centre for Disease Control, Vancouver, BC, Canada, 4Public Health Agency of Canada, Ottawa, ON, Canada, 5National Microbiology Laboratory, Winnipeg, MB, Canada